SCHEMBL459500

SCHEMBL459500

Cc1ccc(F)c([C@H]2CNC[C@]2(Cc2ccccc2)NC(=O)OC(C)(C)C)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 3/20 0.33
NPSR1 Q6W5P4 2/20 0.33
MEN1 O00255 2/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA7 P43166 1/20 0.33
CA14 Q9ULX7 1/20 0.33
GPBAR1 Q8TDU6 1/20 0.33
CHRM3 P20309 1/20 0.33
TP53 P04637 1/20 0.33
GRIN2B Q13224 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1720734 0.92 KMT2A (0.40) HTTKMT2ANPSR1MEN1L3MBTL1
SCHEMBL457233 0.90 KMT2A (0.32) KMT2AMEN1L3MBTL1CA12CA1
SCHEMBL462003 0.90 IDO1 (0.36) HTTKMT2AL3MBTL1CA12CA1
SCHEMBL459152 0.86 CTSS (0.36) HTTKMT2ANPSR1MEN1L3MBTL1
SCHEMBL2013227 0.85 CA12 (0.34) KMT2AL3MBTL1CA12CA1CA7
SCHEMBL462095 0.85 RORC (0.36) HTTKMT2AL3MBTL1CA12CA1
SCHEMBL1726610 0.81 KMT2A (0.37) HTTKMT2ASLC6A2SLC6A4SLC6A3
SCHEMBL2016334 0.81 SLC6A2 (0.39) KMT2ASLC6A2SLC6A4L3MBTL1
SCHEMBL2012019 0.80 KDM1A (0.39) KMT2AL3MBTL1CA12CA1CA7
SCHEMBL2226908 0.78 KMT2A (0.36) KMT2ASLC6A2SLC6A4SLC6A3L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012066077-A1 1,4 DI SUBSTITUTED PYRROLIDINE - 3 - YL -AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2012-05-24 WO disclosed
WO-2011147951-A1 CYCLOAMINO DERIVATIVES AS GPR119 ANTAGONISTS PROSIDION LIMITED (GB) 2011-12-01 WO disclosed